Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 194

The DOI matches its Crossref record.

Identification of Hepatitis C Virus NS5A Inhibitors

Open access
Lemm, Julie A., O'Boyle, Donald, Liu, Mengping, Nower, Peter T., Colonno, Richard, Deshpande, Milind S., Snyder, Lawrence B., Martin, Scott W., St. Laurent, Denis R., Serrano-Wu, Michael H., Romine, Jeffrey L., Meanwell, Nicholas A., Gao, Min · 2010 · Journal of Virology

Abstract

Using a cell-based replicon screen, we identified a class of compounds with a thiazolidinone core structure as inhibitors of hepatitis C virus (HCV) replication. The concentration of one such compound, BMS-824, that resulted in a 50% inhibition of HCV replicon replication was ∼5 nM, with a therapeutic index of >10,000. The compound showed good specificity for HCV, as it was not active against several other RNA and DNA viruses. Replicon cells resistant to BMS-824 were isolated, and mutations were identified. A combination of amino acid substitutions of leucine to valine at residue 31 (L31V) and glutamine to leucine at residue 54 (Q54L) in NS5A conferred resistance to this chemotype, as did a single substitution of tyrosine to histidine at amino acid 93 (Y93H) in NS5A. To further explore the region(s) of NS5A involved in inhibitor sensitivity, genotype-specific NS5A inhibitors were used to evaluate a series of genotype 1a/1b hybrid replicons. Our results showed that, consistent with resistance mapping, the inhibitor sensitivity domain also mapped to the N terminus of NS5A, but it could be distinguished from the key resistance sites. In addition, we demonstrated that NS5A inhibitors, as well as an active-site inhibitor that specifically binds NS3 protease, could block the hyperphosphorylation of NS5A, which is believed to play an essential role in the viral life cycle. Clinical proof of concept has recently been achieved with derivatives of these NS5A inhibitors, indicating that small molecules targeting a nontraditional viral protein like NS5A, without any known enzymatic activity, can also have profound antiviral effects on HCV-infected subjects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/jvi.01360-09

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 194

Metadata

Authors
Lemm, J. A., O'Boyle, D., Liu, M., Nower, P. T., Colonno, R., Deshpande, M. S., Snyder, L. B., Martin, S. W., St. Laurent, D. R., Serrano-Wu, M. H., Romine, J. L., Meanwell, N. A., & Gao, M.
Venue
Journal of Virology
Published
2010-01
Volume
84
Issue
1
Pages
482-491
ISSN
  • 0022-538X (ISSN-L)
  • 1098-5514
OpenAlex
W2070587341
Cited by
194
References
0
FWCI
14.02
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of Hepatitis C Virus NS5A Inhibitors. https://app.cochat.ai/papers/10.1128/jvi.01360-09
The paper
Lemm, J. A., O'Boyle, D., Liu, M., Nower, P. T., Colonno, R., Deshpande, M. S., Snyder, L. B., Martin, S. W., St. Laurent, D. R., Serrano-Wu, M. H., Romine, J. L., Meanwell, N. A., & Gao, M. (2010). Identification of Hepatitis C Virus NS5A Inhibitors. Journal of Virology. https://doi.org/10.1128/jvi.01360-09

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.